| Evolutionary Multi-Objective Design of SARS-CoV-2 Protease Inhibitor Candidates | May 6, 2020 | Drug Design | —Unverified | 0 |
| Computing Absolute Free Energy with Deep Generative Models | May 1, 2020 | Drug Design | —Unverified | 0 |
| Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning | Apr 29, 2020 | Deep Reinforcement LearningDrug Design | —Unverified | 0 |
| Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning | Apr 26, 2020 | Drug DesignDrug Discovery | CodeCode Available | 1 |
| Recognition of potential Covid-19 drug treatments through the study of existing protein-drug and protein-protein structures: an analysis of kinetically active residues | Apr 21, 2020 | Drug Design | —Unverified | 0 |
| Molecular docking studies on Jensenone from eucalyptus essential oil as a potential inhibitor of COVID 19 corona virus infection | Apr 17, 2020 | Drug DesignMolecular Docking | —Unverified | 0 |
| Continuous Representation of Molecules Using Graph Variational Autoencoder | Apr 17, 2020 | DecoderDrug Design | —Unverified | 0 |
| CogMol: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models | Apr 2, 2020 | AttributeDrug Design | —Unverified | 0 |
| Application and Assessment of Deep Learning for the Generation of Potential NMDA Receptor Antagonists | Mar 31, 2020 | Drug DesignDrug Discovery | —Unverified | 0 |
| Direct Coupling Analysis of Epistasis in Allosteric Materials | Mar 13, 2020 | Drug Design | —Unverified | 0 |
